Study assessing the effect of entecavir therapy in a cohort of hepatitis B virus (HBV) compensated cirrhosis patients

Trial Profile

Study assessing the effect of entecavir therapy in a cohort of hepatitis B virus (HBV) compensated cirrhosis patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2016

At a glance

  • Drugs Entecavir (Primary) ; Adefovir dipivoxil; Lamivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2016 New trial record
    • 20 Jul 2015 Interim results (n=91) published in the Chinese Medical Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top